MetaCap

LifeStance Health Group Cash Flow Statement

NASDAQ: LFSTHealth CareMedical/Nursing ServicesUSD

12.42+0.36 (+2.99%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

LifeStance Health Group free cash flow

In fiscal 2025, LifeStance Health Group generated $146.2 million of operating cash flow and spent $36.1 million on capital expenditures. That left free cash flow of $110.0 million, a free-cash-flow margin of 7.7% of revenue. Free cash flow was up 28.4% from the prior year's $85.7 million.

Summary generated from market data by MetaCap's automated system. Methodology

LifeStance Health Group cash flow statement (annual)

LifeStance Health Group annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20192019-12-31
Net Income9.66M-57.44M-186.26M-215.56M-307.20M5.67M
Net Income growth (YoY)————-5518.89%—
Depreciation & Amortization41.62M40.68M37.37M28.92M15.09M3.04M
Stock-Based Compensation74.70M76.17M99.39M187.43M259.44M54.00K
Change in Working Capital-12.16M-9.23M-32.85M-17.43M-52.71M-5.46M
Operating Cash Flow146.15M107.26M-16.88M52.79M9.42M17.05M
Capital Expenditures-36.13M-21.57M-40.52M-79.25M-94.49M-14.31M
Investing Cash Flow-36.13M-21.57M-60.34M-139.46M-194.08M-73.38M
Debt Issued0287.81M57.75M257.32M98.80M55.94M
Debt Repaid-7.25M-289.49M-2.47M-187.77M-311.39M-488.00K
Financing Cash Flow-15.96M-9.95M47.43M47.26M313.86M48.46M
Net Change in Cash94.07M75.75M-29.80M-39.41M129.20M-7.86M
Free Cash Flow110.03M85.69M-57.40M-26.47M-85.07M2.73M

This table shows 6 annual periods of LifeStance Health Group's cash flow statement, from FY 2025 back to FY 2019, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LFST's reporting calendar. What is a cash flow statement?

More financial data